Getting high to cope with COVID-19: Modelling the associations between cannabis demand, coping motives, and cannabis use and problems.

Authors:
Vedelago L; Wardell JD; Kempe T; Patel H; Amlung M and 2 more

Journal:
Addict Behav

Publication Year: 2021

DOI:
10.1016/j.addbeh.2021.107092

PMCID:
PMC8555961

PMID:
34469783

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Addict Behav

Abbreviation: Addict Behav

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Substance-Related Disorders

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Association of smartphone use with abnormal social jetlag among adolescents in Korea before and aft…
Cho Y; In H; Park M and 2 more (2023) - Transparency Score: 3/6
Device and liquid characteristics used with sweet, menthol/mint, and tobacco ENDS liquid flavors: T…
Crespi E; Hardesty JJ; Nian Q and 4 more (2023) - Transparency Score: 3/6
A three-wave panel study on longitudinal relations between problematic social media use and psychol…
Di Blasi M; Salerno L; Albano G and 8 more (2022) - Transparency Score: 4/6
Did the acute impact of the COVID-19 pandemic on drinking or nicotine use persist? Evidence from a …
Pelham WE; Yuksel D; Tapert SF and 11 more (2022) - Transparency Score: 4/6
Factors associated with changes in flavored tobacco products used: Findings from wave 2 and wave 3 …
Bansal-Travers M; Rivard C; Silveira ML and 17 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest James MacKillop is a principal in BEAM Diagnostics Inc., but no BEAM products were used in the data collected. All other authors declare that they have no conflicts of interest. Declaration of Competing Interest JM is a principal in BEAM Diagnostics Inc., but no BEAM products were used in the the data collected. No other authors have declarations."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025